跳至主要内容
临床试验/NCT02898987
NCT02898987招募中不适用

Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients

DatAids39 个研究点 分布在 3 个国家目标入组 30,000 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30,000
试验地点
39
主要终点
Proportion of HIV treated patients with HIV plasma viral load < 50 copies/mL

研究概览

简要总结

The objective of the Dataids cohort is to continue a long-term, prospective collection of clinical, laboratory and therapeutic data on a large cohort of HIV infected patients seeking care in 15 HIV centers in France in order :

  1. to provide and develop a surveillance system to describe clinical practice and temporal changes in the clinical course of HIV and HIV-related co-infections and co-morbidities in France.
  2. to assess the factors associated with the clinical, immunological and virological course of HIV infection and HIV-related co-infections and co-morbidities

The specific objectives are as follows

  • To continue surveillance of HIV infection in France to describe temporal changes
  • To evaluate the efficacy of ART and factors associated with ART efficacy
  • To monitor the uptake and outcome of HCV therapy

详细描述

The Dataids cohort is a prospective observational cohort of 30,000+ patients followed in 15+ HIV centers scattered throughout France. The Dataids cohort is an ongoing collaboration and patients have been enrolled into the study since 2010; the data are collected from the clinics as part of routine care. Included patients should be patients who had a scheduled visit in the outpatient clinic regardless of CD4 cell count, HIV viral load or ART status. For all HIV patients enrolled and under follow up, demographic data, immunological and virological data, serological evidence for infection with hepatitis B virus (HBV), hepatitis C virus (HCV), or syphilis, laboratory, therapeutic and clinical data are collected annually.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV-1 infected patients regardless of CD4 cell count and antiretroviral therapy status

排除标准

  • Patients under 18 years of age
  • Patients without written informed consent

结局指标

主要结局

Proportion of HIV treated patients with HIV plasma viral load < 50 copies/mL

时间窗: From date of enrollment, through study completion, an average of 6 months

次要结局

  • Proportion of HIV/HCV coinfected patients who start treatment with direct acting antivirals agents(From date of enrollment, through study completion, an average of 1 year)
  • proportion of HIV/HCV patients with undetectable HCV viral load after treatment with direct acting antivirals agents(From date of enrollment, through study completion, an average of 1 year)
  • Proportion of HIV patients according to their antiretroviral status : naive, on treatment, therapeutic stop(From date of enrollment, through study completion, an average of 1 year)
  • Proportion of HIV patients with CD4 cells count above 500 /ml(From date of enrollment, through study completion, an average of 1 year)
  • Incidence of aids events among patients enrolled in the cohort study(From date of enrollment, through study completion, an average of 1 year)
  • Incidence of non aids events among patients enrolled in the cohort study(From date of enrollment, through study completion, an average of 1 year)
  • Incidence of antiretroviral modification due to simplification or failure(From date of enrollment, through study completion, an average of 1 year)

研究者

发起方
DatAids
申办方类型
Other
责任方
Sponsor

研究点 (39)

Loading locations...

相似试验